R E S E A R C H H U B Epithalon Research Hub Epithalon (Epitalon) is a synthetic linear tetrapeptide derived from the short- peptide bioregulator research programme, investigated in preclinical and laboratory models examining cellular aging, telomere-associated biology and gene-expression-related processes. Epithalon Synthetic Peptide Tetrapeptide 4 Amino Acids Linear Structure First order ? Get 10% OFF with this code : 1 storder Type to start searching ... 0 Epithalon Peptide Vial $16.33 – $111.33 Select options Epithalon Peptide Capsules $86.69 Add to cart $ USD ⌄ C H E M I C A L N A M E L-alanyl-L-alpha-glutamyl-L-alpha-aspartyl- glycine M O L E C U L A R F O R M U L A C14H22N4O9 M O L E C U L A R W E I G H T 390.34 g/mol C O M P O U N D C L A S S Synthetic linear tetrapeptide O N T H I S P A G E 01 Technical Overview 02 Chemical Classi cation 03 Molecular Characteristics 04 Mechanism Under Investigation 05 Experimental Research Areas 06 Analytical Veri cation 07 Storage & Handling 08 Questions researchers ask Epithalon DSIP Peptide Stack $31.10 Add to cart Thymalin Epithalon Peptide Stack $51.23 Add to cart 0 1 Technical Overview Four amino acid residues make up the synthetic tetrapeptide Epithalon, also known as Epitalon: Ala- Glu-Asp-Gly (AEDG). It is also known as alanyl-glutamyl-aspartyl-glycine in scienti c databases and is categorized as an ultra-short synthetic peptide bioregulator. It differs from bigger peptide hormones and proteins, which usually have more intricate secondary and tertiary architectures, because to its tiny molecular size and linear shape. Epitalon was developed from research led by Vladimir Khavinson and colleagues into Epithalamin, a peptide-rich extract obtained from bovine pineal tissue. The AEDG sequence was synthesised based on the amino-acid composition of this extract and subsequently investigated as a de ned molecular entity. Scienti c literature therefore distinguishes synthetic Epitalon from the more chemically heterogeneous Epithalamin preparation. Epitalon is recognised principally within experimental research concerning short-peptide bioregulation, pineal biology, cellular ageing, gene regulation and telomere-associated molecular biology. Studies have employed in vitro cellular systems, animal models and molecular modelling to investigate its biochemical characteristics and potential molecular interactions. However, several aspects of its mechanism remain unresolved, and the evidence base includes substantial contributions from the original research groups. Within laboratory settings, synthetic Epitalon provides a chemically de ned AEDG research peptide suitable for biochemical, molecular and cell-based investigations. Its short sequence also permits straightforward chemical synthesis and analytical characterisation compared with larger proteins. 0 2 Chemical Classification C H E M I C A L N A M E L-alanyl-L-alpha-glutamyl-L-alpha-aspartyl-glycine C O M M O N N A M E ( S ) Epitalon; Epithalon; Epithalone; AEDG Peptide M O L E C U L A R F O R M U L A C14H22N4O9 M O L E C U L A R W E I G H T 390.34 g/mol P U R I T Y 98.7% C A S N U M B E R 307297-39-8 C O M P O U N D C L A S S Synthetic linear tetrapeptide O R I G I N Synthetic; derived from Epithalamin-associated pineal peptide research A M I N O A C I D S E Q U E N C E H-Ala-Glu-Asp-Gly-OH 0 3 Molecular Characteristics Because Epithalon only has four amino acids, it lacks the stable tertiary architecture found in larger proteins. There is no evidence of a permanent conventional secondary structure, and it is a flexible linear molecule. The peptide has an acidic, negatively charged nature around physiological pH due to the many ionizable carboxyl groups provided by its glutamic acid and aspartic acid residues. Epithalon is strongly hydrophilic rather than lipid-soluble. Its polar and ionisable groups favour interaction with aqueous environments, although practical solubility depends on pH, concentration, counter-ion and formulation. The basic AEDG molecule contains no disulphide bonds, glycosylation or other complex post- translational modi cations. As an unmodi ed short linear peptide, Epithalon remains potentially susceptible to chemical and enzymatic degradation in solution. Lyophilisation and controlled laboratory storage are therefore commonly used to maintain sample integrity. 0 4 Mechanism Under Investigation Current laboratory investigations have examined Epithalon (Epitalon; AEDG) as a synthetic tetrapeptide whose molecular mechanism remains under investigation. Unlike classical peptide hormones, Epithalon does not currently have a conclusively identi ed cognate cell-surface receptor. Published experimental studies have instead focused on potential interactions with telomere-associated processes, gene transcription, chromatin organisation and intracellular regulatory mechanisms. Telomerase and Telomere-Associated Mechanisms Investigations of Epithalon in cultured human cells that look at telomerase activity and telomere- associated molecular alterations are described in published experimental studies. The ribonucleoprotein enzyme complex telomerase is in charge of appending repeating nucleotide sequences to the ends of chromosomes. Investigations into whether the peptide interacts directly or indirectly with regulatory systems governing telomerase expression or activity have been spurred by experimental observations involving AEDG. There is currently no known direct molecular binding target inside the telomerase complex. Gene Expression and Chromatin Regulation In vitro models have explored whether short peptides such as AEDG can participate in transcriptional regulation. Studies from the peptide-bioregulator literature have examined interactions between short peptides, DNA and chromatin-associated proteins. Molecular modelling and biochemical approaches have also investigated sequence-speci c peptide–DNA interactions as a possible mechanism through which transcriptional activity could be modi ed. Epigenetic and Nuclear Interactions Experimental research has examined the broader hypothesis that Epithalon may interact with nuclear regulatory processes, including chromatin accessibility and gene-expression networks. Investigations involving peptide–DNA binding, histone-associated mechanisms and transcriptional responses have contributed to this proposed model. However, these mechanisms remain substantially less characterised than conventional receptor-mediated peptide signalling. Pineal and Neuroendocrine Molecular Biology Epithalon has additionally been examined in experimental models of pineal and neuroendocrine regulation, reflecting its historical development from research into pineal-derived peptide preparations. Gene-expression and biochemical studies have investigated molecular pathways associated with pineal cellular regulation. Overall, Epithalon is best characterised as an investigational peptide bioregulator without a de nitively established primary receptor or molecular target. Telomerase-associated regulation, transcriptional mechanisms and peptide–chromatin interactions represent the principal mechanistic areas described in the experimental literature. The information provided is based on the results of laboratory and preclinical studies of Epithalon and does not prove clinical ef cacy, nor does it con rm that the substance is suitable for use in humans. Detailed supporting studies are listed in the references. 0 5 Experimental Research Areas 0 1 Telomere and Telomerase Biology One of the most distinctive areas of Epithalon (Epitalon; AEDG) research concerns telomere- associated molecular biology. In vitro investigations have examined telomerase activity, telomere dynamics and cellular replicative processes following AEDG exposure. These experiments have primarily employed cultured human somatic cells and cytogenetic or molecular techniques to characterise telomere-related responses. 0 2 Peptide–DNA Interactions Within the more general subject of ultra-short peptide interactions with nucleic acids, epithalon has been studied. AEDG's ability to bind to certain DNA sequences or structures has been investigated thru computational and experimental research. Potential peptide–DNA interactions and their molecular speci city have been characterized using methods such as spectroscopic techniques and molecular modeling. 0 3 Gene Expression and Transcriptional Regulation Epithalon has been studied in relation to the regulation of gene expression. Transcriptional responses after peptide exposure, including genes linked to cellular differentiation and regulatory processes, have been studied in cell-based investigations. This study is a component of a larger examination into the potential interactions between nuclear molecular machinery and short peptide bioregulators. 0 4 Chromatin and Epigenetic Research Another experimental area concerns interactions between short peptides and chromatin-associated structures. Studies within the peptide-bioregulator eld have explored relationships between AEDG, histones, chromatin organisation and transcriptional accessibility. These proposed mechanisms remain under investigation and have not established a single de nitive nuclear target for Epithalon. 0 5 Pineal Cell and Neuroendocrine Biology Because Epithalon originated from research involving peptide preparations associated with the pineal gland, experimental studies have examined AEDG in models relevant to pineal and neuroendocrine molecular biology. Investigations have considered gene expression, protein regulation and cellular signalling within pineal-related experimental systems. 0 6 Cellular Senescence Models Epithalon has also been investigated using experimental models of cellular ageing and replicative senescence. Cultured cells at different stages of their replicative lifespan have been employed to examine chromosome-associated changes, gene-expression patterns and other molecular markers under controlled conditions. This area overlaps substantially with the peptide’s telomere research. 0 7 Structural and Computational Peptide Research Molecular modelling and biophysical studies have been used to examine the structural behaviour of the AEDG tetrapeptide, including its possible interactions with DNA and other macromolecules. Such research provides a framework for investigating how an extremely short, negatively charged peptide might participate in molecular recognition despite lacking the complex structure of larger peptide hormones. 0 6 Analytical Verification Analytical veri cation of Epithalon (Epitalon; AEDG) should establish the identity and purity of the tetrapeptide Ala-Glu-Asp-Gly. Following Solid Phase Peptide Synthesis (SPPS), preparative reverse- phase HPLC may be used to separate the target AEDG peptide from deletion sequences, residual reagents and other synthesis-related impurities. Analytical RP-HPLC can be used to compare batch consistency and offers a quantitative evaluation of chromatographic purity. LC-MS, or high-resolution mass spectrometry, offers orthogonal identity con rmation by con rming the anticipated molecular species because unadulterated Epithalon has a calculated molecular mass of roughly 390.35 Da. Tandem mass spectrometry (MS/MS) or amino acid analysis can offer sequence or compositional information when further con rmation is needed. Because the free peptide and salt forms, such Epitalon acetate, have differing chemical compositions, analytical documentation should also differentiate between the two. Peptide identity, sequence, batch number, HPLC purity, observed molecular mass, analytical technique, and relevant speci cation limitations should all be documented in a batch-speci c Certi cate of Analysis (CoA). C E R T I F I C A T E O F A N A L Y S I S Batch 20250910015 Document Download PDF H P L C Batch 20250910015 Document Download PDF T H I R D P A T Y C E R T I F I C A T E Batch 12 May 2026 Document Download PDF 0 7 Storage & Handling Epithalon should be stored at 2–8°C in its original, tightly sealed container. Keep the material in a dry environment and protect it from moisture, excessive heat, and direct light. When handling Epithalon, keep the container closed until the material is needed and limit its exposure to room conditions. Allow a refrigerated vial to reach room temperature before opening to help prevent condensation. Reseal the container after handling and return it to the recommended storage conditions. S U P P L I E D A S Lyophilized Powder S T O R A G E 2–8°C, away from light R E C O N S T I T U T I O N Sterile diluent A F T E R R E C O N S T I T U T I O N Refrigerate, limit freeze - thaw 0 8 Questions researchers ask Is Epithalon the same as Epitalon? − Yes. The identical synthetic tetrapeptide, Ala-Glu-Asp-Gly (AEDG), is frequently transliterated as Epithalon or Epitalon. Whilst Epithalon is commonly found in commercial and research settings, Epitalon is especially prevalent in scienti c journals and chemical databases. Is Epithalon naturally occurring or synthetic? + What is the difference between Epithalon and Epithalamin? + Does Epithalon have an identi ed receptor? + Why is telomerase investigated in Epithalon research? + Have peptide–DNA interactions been investigated for Epithalon? + What experimental models have been used to investigate Epithalon? + How does Epithalon differ from other Khavinson peptide bioregulators? + Epithalon is provided for laboratory research and scienti c investigation only. It is not for human consumption or veterinary use and is not intended for administration. It is not intended to diagnose, treat, cure, or prevent any disease or medical condition. Information on this page is provided for scienti c research purposes only. R E F E R E N C E S Khavinson VKh, Bondarev IE, Butyugov AA. Epithalon peptide induces telomerase activity and telomere elongation in human somatic cells. Bull Exp Biol Med. 2003 Jun;135(6):590-2. doi: 10.1023/a:1025493705728. View source Khavinson V, Diomede F, Mironova E, Linkova N, Tro mova S, Trubiani O, Caputi S, Sinjari B. AEDG Peptide (Epitalon) Stimulates Gene Expression and Protein Synthesis during Neurogenesis: Possible Epigenetic Mechanism. Molecules. 2020 Jan 30;25(3):609. doi: 10.3390/molecules25030609. View source Lezhava T, Monaselidze J, Kadotani T, Dvalishvili N, Buadze T. Anti-aging peptide bioregulators induce reactivation of chromatin. Georgian Med News. 2006 Apr;(133):111-5. View source Araj SK, Brzezik J, M ą dra-Gackowska K, Szeleszczuk Ł . Overview of Epitalon-Highly Bioactive Pineal Tetrapeptide with Promising Properties. Int J Mol Sci. 2025 Mar 17;26(6):2691. doi: 10.3390/ijms26062691. View source A V A I L A B L E N O W Epithalon from Peptide Works Epithalon Peptide Vial $16.33 – $111.33 Select options Epithalon Peptide Capsules $86.69 Add to cart Epithalon DSIP Peptide Stack $31.10 Add to cart Thymalin Epithalon Peptide Stack $51.23 Add to cart All products on this website are supplied for laboratory research purposes only. They are not intended for human or animal consumption or ingestion of any kind. Information, statements and products featured on this site are for research and educational purposes only and are not designed to diagnose, treat, cure, or prevent any condition. Subscribe to our newsletter for discounts and updates you @ lab com Subscribe Batch and catalogue noti cations only — no dosing advice, no protocols, no discount spam. S H O P All compounds Popular peptides Peptide information L E A R N FAQs Blog About us O R D E R S Shipping & returns Payment information Track an order Contact L E G A L Privacy policy Terms & conditions Sitemap © 2026 Peptide Works. All rights reserved. Payment partners R E S E A R C H H U B GHK-Cu Peptide Research Hub GHK-Cu is a copper–peptide complex comprising glycyl-L-histidyl-L-lysine (GHK) associated with copper, classi ed as a tripeptide-based copper complex for biochemical research. Copper–peptide complex tripeptide copper-binding peptide First order ? Get 10% OFF with this code : 1 storder Type to start searching ... 0 GHK Cu Peptide Vial $11.88 – $84.61 Select options GHK Cu Peptide Capsules $79.16 Add to cart $ USD ⌄ BPC 157 GHK Cu Thymosin Alpha -1 Peptide Stack $92.29 Add to cart BPC 157 TB 500 GHK Cu Peptide Stack $41.76 Add to cart GHK Cu PTD DBM Peptide Stack $29.95 Add to cart GHK Cu TB 500 Peptide Stack $24.76 Add to cart M O L E C U L A R W E I G H T 340.5 g/mol M O L E C U L A R F O R M U L A 2C14H24N6O4·Cu·2C2H4O2 C A S N U M B E R 130120-57-9 C O M P O U N D C L A S S Copper–peptide complex, tripeptide O N T H I S P A G E 01 Technical Overview 02 Chemical Classi cation 03 Molecular Characteristics 04 Mechanism Under Investigation 05 Experimental Research Areas 06 Analytical Veri cation 07 Storage & Handling 08 Questions researchers ask 0 1 Technical Overview GHK Basic Topical $29.92 Add to cart GHK Cu Topical $122.41 Add to cart GHK-Cu is a copper-binding tripeptide complex formed when glycyl-L-histidyl-L-lysine (GHK) coordinates a copper(II) ion. GHK itself is a naturally occurring tripeptide rst identi ed in human plasma and has subsequently been detected in other biological fluids and tissues. The copper complex is commonly referred to as GHK-Cu, copper tripeptide-1 or copper(II)-GHK. Structurally, GHK contains three amino acids—glycine, histidine and lysine—whose functional groups provide coordination sites for Cu² ⁺ . Copper-binding studies have investigated the resulting complex using spectroscopic, electrochemical and structural techniques, demonstrating that metal coordination substantially influences the molecular properties of the peptide. GHK-Cu has been investigated primarily in experimental research concerning copper homeostasis, extracellular-matrix biology, cellular signalling, gene expression and tissue-remodelling processes. Cell-based studies have examined responses involving broblasts and other skin-associated cell types, including changes in extracellular-matrix components and enzymes involved in matrix turnover. Other research has explored antioxidant-associated mechanisms and the ability of the GHK ligand to participate in copper transport and exchange reactions. Unlike receptor-selective peptide hormones, GHK-Cu does not have a single, universally accepted cognate cell-surface receptor that explains all reported biological observations. Its proposed mechanisms instead involve copper coordination together with multiple cellular and molecular interactions. GHK-Cu should be analytically separated from uncomplexed GHK for laboratory research since copper coordination influences its physicochemical and spectroscopic properties. Therefore, rather than just being an unaltered synthetic peptide, it is better described as an experimental copper– peptide combination. 0 2 Chemical Classification C H E M I C A L N A M E Copper(II) glycyl-L-histidyl-L-lysine complex C O M M O N N A M E ( S ) GHK-Cu, Copper Tripeptide-1, Copper GHK M O L E C U L A R F O R M U L A 2C14H24N6O4·Cu·2C2H4O2 M O L E C U L A R W E I G H T 340.5 g/mol C O M P O U N D C L A S S Copper–peptide complex, tripeptide O R I G I N Naturally occurring human plasma peptide P U R I T Y 99.80% C A S N U M B E R 130120-57-9 A M I N O A C I D S E Q U E N C E H-Gly-His-Lys-OH 0 3 Molecular Characteristics GHK-Cu is a coordination complex formed between the tripeptide glycyl-L-histidyl-L-lysine (GHK) and a copper(II) ion (Cu² ⁺ ). The peptide component consists of only three amino-acid residues— glycine, histidine and lysine—making GHK substantially smaller than conventional peptide hormones and protein growth factors. Uncomplexed GHK has a molecular formula of C ₁₄ H ₂₄ N ₆ O ₄ and a molecular mass of approximately 340.38 Da. One of GHK's unique molecular features is its strong af nity for copper. Cu² ⁺ coordination involves donor groups in the peptide, namely the nitrogen/oxygen functionality of the peptide backbone, the histidine imidazole nitrogen, and the N-terminal amino group. This produces a unique environment that alters the electrical and spectroscopic properties of the peptide when compared to metal- free GHK. GHK-Cu is a small, water-compatible and highly polar complex containing several ionisable functional groups. Its overall charge and coordination behavior vary with pH, ionic strength and the existence of competing metal-binding molecules. Unlike larger proteins, it has no disul de bonds, glycosylation or stable tertiary protein architecture. An important analytical consideration is that GHK and GHK-Cu are chemically distinct species. Veri cation of GHK-Cu should therefore establish not only peptide identity but also copper content and coordination state. Techniques such as HPLC and mass spectrometry can characterise the peptide component, while UV-visible, EPR or other spectroscopic methods can provide complementary information concerning Cu² ⁺ complex formation. 0 4 Mechanism Under Investigation Experimental studies have examined GHK-Cu in relation to copper complex formation, broblast activity, extracellular matrix synthesis, and matrix metalloproteinase expression. Copper-complex formation was associated with the observed biological activity of GHK, while the free lysine side chain was reported to be important for activity. Extracellular Matrix Synthesis In cultured broblasts, GHK-Cu increased collagen synthesis and stimulated synthesis of glycosaminoglycans, particularly extracellular dermatan sulfate and cell-layer-associated heparan sulfate. Experimental wound models also reported increased type I and type III collagen expression and increased extracellular matrix accumulation. Matrix Metalloproteinase Expression GHK-Cu increased MMP-2 levels and MMP-2 mRNA in cultured broblasts and increased secretion of TIMP-1 and TIMP-2. Experimental wound studies also reported changes in MMP-2 and MMP-9 expression and activation during the experimental wound-remodeling period. Growth-Factor Expression In cultured normal and irradiated human broblasts, GHK-Cu increased broblast growth and was associated with increased production of basic broblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) in irradiated broblasts. This summary reflects ndings reported in published preclinical and in vitro research. The original studies supporting this information are listed in the references. 0 5 Experimental Research Areas 0 1 Copper Coordination and Metal-Binding Chemistry A research area particularly speci c to GHK-Cu concerns the coordination of Cu² ⁺ by the GHK tripeptide. Spectroscopic, electrochemical and computational approaches have been used to investigate copper-binding af nity, coordination geometry and changes in complex formation under different pH and chemical environments. These studies help distinguish copper-complexed GHK from the metal-free peptide. 0 2 Extracellular Matrix and Fibroblast Research GHK-Cu has been extensively investigated in broblast-based experimental systems. Studies have examined changes in collagen, glycosaminoglycans and other extracellular-matrix components following exposure to the copper–peptide complex. Researchers have also investigated enzymes involved in matrix synthesis, degradation and remodelling. 0 3 Matrix Metalloproteinase Regulation The relationship between GHK-Cu and matrix metalloproteinases (MMPs) and their endogenous tissue inhibitors has been studied experimentally. Instead of addressing matrix buildup as a separate process, these investigations examine how the peptide complex may affect the equilibrium between extracellular-matrix synthesis and breakdown. 0 4 Cellular Migration and Tissue-Remodelling Models GHK-Cu has been studied in cell culture and preclinical models during processes related to tissue remodeling and cell migration. Cellular responses during matrix reorganization and repair-associated signaling have been studied using broblasts and other skin-associated experimental systems. 0 5 Oxidative and Redox Biology Because GHK coordinates a redox-active copper ion, its behaviour has also been investigated in oxidative-stress and copper-redox models. Researchers have examined interactions with reactive oxygen species, oxidative damage and antioxidant-associated molecular processes. These effects are context-dependent because copper chemistry itself can participate in both oxidative and protective reactions. 0 6 Gene-Expression Research Transcriptomic and cell-based studies have explored how exposure to GHK and GHK-Cu may influence patterns of gene expression. Researchers have reported changes involving genes associated with extracellular-matrix regulation, cellular stress responses, inflammatory signaling and tissue-remodelling processes. Rather than pointing to one speci c transcriptional pathway, the available research suggests that GHK-Cu may be associated with changes across several molecular networks. However, these responses can differ depending on the cell type and experimental conditions, and a single pathway responsible for all reported effects has not been established. 0 7 Copper Transport and Cellular Availability The capacity of small peptides to bind, transport, and exchange copper with biological molecules has been investigated using GHK-Cu as a model. These studies examine whether GHK can affect the availability of Cu2+ for proteins and cellular processes while limiting the quantity of free copper ions. 0 8 Structural and Analytical Characterisation Analytical research focuses on con rming both components of the GHK-Cu complex. HPLC and mass spectrometry can characterise the GHK component, while UV-visible spectroscopy, electron paramagnetic resonance (EPR) and metal analysis can investigate copper coordination. This is particularly important because uncomplexed GHK and GHK-Cu represent chemically distinct experimental materials. 0 6 Analytical Verification Analytical veri cation of GHK-Cu should con rm both the identity of the GHK tripeptide and the presence of coordinated Cu² ⁺ , as GHK-Cu and metal-free GHK are chemically distinct materials. RP- HPLC can be used to assess the overall chromatographic purity of the sample and detect peptide- related impurities that may be present. LC-MS or high-resolution mass spectrometry can then provide additional con rmation of the GHK component by comparing its observed molecular mass with the expected value. Together, these techniques provide a more complete assessment of the peptide component and help establish the identity and quality of the material being analysed. The copper content of GHK-Cu should also be measured separately using an elemental analysis technique such as ICP-MS or ICP-OES. This allows the amount of copper present to be determined and compared with the peptide content. However, measuring copper alone does not con rm that the Cu² ⁺ ion is properly coordinated with GHK. Spectroscopic methods can thus offer useful supplementary data. While electron paramagnetic resonance (EPR) can offer more in-depth information about the chemical environment and coordination of the Cu2+ ion, UV-visible spectroscopy can show distinctive changes linked to the development of the copper–peptide complex. When combined, these techniques offer more proof that the sample has the desired GHK- Cu complex as opposed to just GHK and free copper. Therefore, peptide identity, chromatographic purity, copper content, pertinent spectroscopic evidence, batch identi cation, and the analytical techniques employed should all be recorded in a batch-speci c Certi cate of Analysis. C E R T I F I C A T E O F A N A L Y S I S Batch 20250912014 Method COA 2026 Document Download PDF H P L C Batch 20250912014 Method HPLC 2026 Document Download PDF T H I R D P A R T Y C E R T I F I C A T E Batch 11 August 2026 Document Download PDF 0 7 Storage & Handling Store GHK-Cu according to the speci ed conditions for the supplied chemical form and batch. Lyophilized GHK-Cu should remain in its original sealed container and be protected from moisture, excessive light, heat, and unnecessary temperature fluctuations. Store the supplied material at 2– 8°C. During laboratory handling, keep the container sealed when not in use and minimize unnecessary exposure to environmental conditions. S U P P L I E D A S Lyophilized Powder in Vial S T O R A G E Store at 2–8°C H A N D L I N G Reconstitution Required 0 8 Questions researchers ask Is GHK-Cu naturally occurring or synthetic? −